Fingerprint
Dive into the research topics of 'Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors
Hitisha K. Patel, Nianjun Tao, Kyung Min Lee, Mariela Huerta, Heike Arlt, Tara Mullarkey, Steven Troy, Carlos L. Arteaga, Teeru Bihani
Research output: Contribution to journal › Article › peer-review
49
Scopus
citations